Surprisingly, infusion of Angiotensin II (Ang II), a vasoactive substance of the renin-angiotensin system, known to function in vasoconstriction, aldosterone release, and cell growth was shown to induce a substantial incidence of AD symptoms in vivo via c-Abl activation. This evidence concerns the gene ABL1 and Alzheimer disease.